Credit Corp has ceased discussions regarding its proposal to acquire 100% of Humm Group. The withdrawal follows a material reduction in the bid price after commercial due diligence investigations. The ...
Accendra Health (NYSE:ACH) reported first-quarter 2026 results that met internal expectations as the company nears the finish line of its transformation into a specialized home-based care provider.
Oracle (NYSE:ORCL) reported record fourth-quarter and full-year 2026 financial results, with broad-based growth across its Cloud Infrastructure and Cloud Applications businesses. Total Q4 revenues ...
UnitedHealth Group (NYSE:UNH) today reported financial results for the first quarter of 2026, delivering growth across its primary business platforms and raising its full-year earnings outlook. The ...
Netflix (NASDAQ:NFLX) reported first-quarter 2026 results that showcased resilient top-line momentum but raised concerns regarding near-term profitability and guidance. The streaming giant generated ...
Coronado Global Resources (ASX:CRN) has finalised an agreement to divest 100% of its interest in the Logan Mining Complex, located in West Virginia, USA. The Australian-listed coal producer will sell ...
The federal government is set to unveil a sweeping overhaul of negative gearing, capital gains tax, and trust distributions. The centrepiece of the reform is a strategic wind-back of negative gearing, ...
A Los Angeles County Superior Court jury has ordered Johnson & Johnson (NYSE:JNJ) to pay $32 million to the family of a California woman who died from pleural mesothelioma, concluding that her fatal ...
A Bitcoin holder posting as cprkrn on X said Anthropic’s Claude AI helped recover 5 Bitcoin from a wallet locked for more than 11 years after analysing files from an old college computer. The user ...
Oracle (NYSE:ORCL) delivered third-quarter fiscal 2026 results on Tuesday that exceeded Wall Street expectations, bolstered by a massive wave of demand for its artificial intelligence (AI) cloud ...
Accent Group (ASX:AX1) updated the market on a challenging second half for the 2026 financial year, citing a downturn in consumer sentiment and an ongoing investigation by the Australian Securities ...
Krystal Biotech (NASDAQ:KRYS) reported robust financial results for the first quarter of 2026, highlighted by continued commercial momentum for VYJUVEK, the first and only redosable gene therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results